Trials / Unknown
UnknownNCT06132633
A Pilot Study for Adaptation of Neospot Device for Health Care at Primary Health Facilities in Kenya
A Pilot Study for the Adaptation of Neospot Device for Health Care Among Out-Patients at Primary Health Facilities in Nairobi and Kajiado Counties, Kenya
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 159 (estimated)
- Sponsor
- Neopenda, PBC · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Neospot device is a 5-in-1 wearable vital signs monitor designed to measure temperature, blood pressure, pulse rate (PR), respiratory rate (RR) and blood oxygen saturation (SPO2). We propose to study the experiences of patients and nurses regarding spot measurement of vital signs at the outpatient department in primary care facilities in Kenya. The study aims to investigate the capability, opportunity, and motivation of nurses to use the Neospot device for vital signs measurement in level 3 facilities in Kenya by validating the accuracy of the Neospot and assessing the experience of patients while using the Neospot, the study also aims to assess the experiences of nurses as they use the Neospot and determine how the Neospot affects their workflow.
Detailed description
This study intends to investigate the experiences of both nurses and patients in the use of a specific brand of such a device known as the 'neospot' device in various sub county, health centres in Kenya. The study also aims at finding out whether the device affects the rate and efficiency of how nurses work in these facilities. The study will apply a cross sectional design, three facilities will be used as the sampling frame two urban facilities from Nairobi County and one peri urban rural facility from Kajiado county. The participants will be selected randomly. Data will be obtained from a total of 159 randomly selected patients, all the nurses who will be on duty will also be included as participants in the study and the team leaders will be interviewed as key informants for qualitative data. Quantitative data will be analysed using SPSS version 24 for descriptive and inferential statistics, NVIVO software will be used to analyse the qualitative data to determine the themes. Study Duration: Data collection, analysis and report writing will take 4 ½ months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neospot vitals measurement | Vitals of participants in the intervention group will be measured using neospot alongside standard of care measurement. |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-02-01
- Completion
- 2024-04-01
- First posted
- 2023-11-15
- Last updated
- 2023-11-15
Locations
1 site across 1 country: Kenya
Source: ClinicalTrials.gov record NCT06132633. Inclusion in this directory is not an endorsement.